GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » 5-Year Yield-on-Cost %

Wuxi AppTec Co (SHSE:603259) 5-Year Yield-on-Cost % : 2.01 (As of Apr. 29, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co 5-Year Yield-on-Cost %?

Wuxi AppTec Co's yield on cost for the quarter that ended in Dec. 2023 was 2.01.


The historical rank and industry rank for Wuxi AppTec Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:603259' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.13   Med: 0.43   Max: 2.12
Current: 2.01


During the past 10 years, Wuxi AppTec Co's highest Yield on Cost was 2.12. The lowest was 0.13. And the median was 0.43.


SHSE:603259's 5-Year Yield-on-Cost % is ranked worse than
54.05% of 74 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.38 vs SHSE:603259: 2.01

Competitive Comparison of Wuxi AppTec Co's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Wuxi AppTec Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's 5-Year Yield-on-Cost % falls into.



Wuxi AppTec Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Wuxi AppTec Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Wuxi AppTec Co  (SHSE:603259) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Wuxi AppTec Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co (SHSE:603259) Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.

Wuxi AppTec Co (SHSE:603259) Headlines

No Headlines